Skip to content

Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

Analysis of the Impact of Using a Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01193998
Enrollment
186
Registered
2010-09-02
Start date
2010-09-30
Completion date
2014-06-30
Last updated
2014-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Heart Failure, Dyspnea, Shortness of Breath

Brief summary

The purpose of this study is to evaluate a validated diagnostic prediction model in the appropriate diagnosis of Acute Heart Failure (AHF) in patients presenting at the emergency department with undifferentiated dyspnea.

Interventions

OTHERTreatment as per model probability

Patients randomized to the arm where the clinician is exposed to the model results should be treated as per the model probability (i.e. if the model probability suggests AHF the clinician should treat for AHF).

OTHERTreatment as per usual care

Patients randomized to the arm where the clinician is blinded to the model results will undergo diagnostic tests and receive treatment as per the clinician's judgment and usual care standards.

Sponsors

Roche Pharma AG
CollaboratorINDUSTRY
Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Presentation to the ED with undifferentiated shortness of breath

Exclusion criteria

* Dyspnea of obvious cause, e.g. chest trauma, obvious clinical exacerbation of known chronic obstructive disease * Obvious pulmonary edema in a patient with a known diagnosis of HF and recently admitted to hospital for HF * Clinician does not plan to treat for AHF at all, but rather to pursue other causes of dyspnea (i.e., probability of AHF ≤ 20%) * Clinician plans to treat for AHF and not to pursue other causes of dyspnea (i.e., probability of AHF ≥ 80%) * Acute coronary syndrome within one month * Chronic renal failure (serum creatinine ≥ 250 mol/l) * Anticipated life expectancy \< 6 months due to non-cardiovascular causes * Participation in another interventional outcome trial * Inability to obtain informed consent, including inability of patient to understand English

Design outcomes

Primary

MeasureTime frame
Comparison of diagnostic model versus clinical judgment in appropriate diagnosis of Acute Heart Failure in dyspneic emergency department patients60 days after patient presentation to the emergency department

Secondary

MeasureTime frame
Determine if use of the diagnostic prediction model leads to cost savings and better health outcomesFrom randomization until 60 days after patient presentation to the emergency department

Countries

Canada, New Zealand, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026